Cargando…
Lysophosphatidic Acid Receptor 1- and 3-Mediated Hyperalgesia and Hypoalgesia in Diabetic Neuropathic Pain Models in Mice
Lysophosphatidic acid (LPA) signaling is known to play key roles in the initiation and maintenance of various chronic pain models. Here we examined whether LPA signaling is also involved in diabetes-induced abnormal pain behaviors. The high-fat diet (HFD) showing elevation of blood glucose levels an...
Autores principales: | Ueda, Hiroshi, Neyama, Hiroyuki, Matsushita, Yosuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465054/ https://www.ncbi.nlm.nih.gov/pubmed/32824296 http://dx.doi.org/10.3390/cells9081906 |
Ejemplares similares
-
Peripheral mechanisms of neuropathic pain – involvement of lysophosphatidic acid receptor-mediated demyelination
por: Ueda, Hiroshi
Publicado: (2008) -
Lysophosphatidic acid LPA(1) and LPA(3) receptors play roles in the maintenance of late tissue plasminogen activator-induced central poststroke pain in mice
por: Ueda, Hiroshi, et al.
Publicado: (2018) -
Lysophosphatidic acid and its receptors LPA(1) and LPA(3) mediate paclitaxel-induced neuropathic pain in mice
por: Uchida, Hitoshi, et al.
Publicado: (2014) -
Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain
por: Ma, Lin, et al.
Publicado: (2009) -
Red induces hyperalgesia and white induces hypoalgesia regardless of pain modality
por: Wiercioch-Kuzianik, Karolina, et al.
Publicado: (2023)